These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18637590)

  • 1. [Experimental treatment using combined Fructus psoraleae and dihydroartemisinin in mouse cryptosporidiosis].
    Chen YF; Qin YH; Zheng LL; Dai XD; Ren YX; Nie DP; Cui Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):67-9. PubMed ID: 18637590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of radix sophorae flavescentis mixture on intestinal mucosa in mice infected with Cryptosporidium parvum].
    Ji R; Cui W; Liang RW; Guan ZY; Li RF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):275-9. PubMed ID: 24812877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
    Abdou AG; Harba NM; Afifi AF; Elnaidany NF
    Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
    Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
    Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice.
    You X; Mead JR
    Parasitology; 1998 Dec; 117 ( Pt 6)():525-31. PubMed ID: 9881376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
    Gamra MM; el-Hosseiny LM
    J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newborn mouse Cryptosporidium parvum infection model: its application to the study of therapeutic and prophylactic measures for controlling cryptosporidiosis in ruminants.
    Martín-Gómez S; Alvarez-Sánchez M; Rojo-Vázquez F
    Parasitol Res; 2006 Jun; 99(1):1-6. PubMed ID: 16447067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NMRI suckling mouse model for the evaluation of infectivity of Cryptosporidium parvum oocysts.
    Xunde LI; Brasseur P
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(2):94-6. PubMed ID: 12567724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
    Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
    [No Abstract]   [Full Text] [Related]  

  • 15. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Rasmussen KR; Healey MC; Cheng L; Yang S
    J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice.
    Del Coco VF; Córdoba MA; Sidoti A; Santín M; Drut R; Basualdo JA
    Vet Parasitol; 2012 Dec; 190(3-4):411-7. PubMed ID: 22818787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
    Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats.
    Rehg JE
    J Parasitol; 1996 Feb; 82(1):158-62. PubMed ID: 8627487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.